That holds doubly true for Medicago, a Canadian biopharma company. Medicago uses plants to produce vaccine and therapeutic candidates, and the platform has found new purpose in the age of coronavirus.

So Medicago, a clinical-stage biopharmaceutical company located in Quebec, Canada, is harnessing a plant-based transient expression process to produce pharmaceutical-grade proteins in a matter of ...

Japanese pharmaceutical giant Mitsubishi Tanabe Pharma Corp. announced that a COVID-19 vaccine derived from a type of tobacco plant and developed by Medicago Inc., the Osaka-based company’s ...